Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
genetic disorder
|
| gptkbp:advertising |
educational campaigns
patient advocacy organizations National Angioedema Awareness Day |
| gptkbp:associatedWith |
C1 inhibitor gene mutations
|
| gptkbp:causedBy |
C1 inhibitor deficiency
|
| gptkbp:clinicalTrials |
C1 inhibitor therapy
bradykinin receptor antagonists newer therapies |
| gptkbp:community_service |
C1 inhibitor levels
C4 levels |
| gptkbp:demographics |
1 in 50,000 to 1 in 150,000
|
| gptkbp:diseaseResistance |
genetic testing
clinical evaluation chronic condition variable severity can be managed with treatment |
| gptkbp:emergencyServices |
oxygen therapy
epinephrine intubation if necessary |
| gptkbp:geneticDiversity |
11q12.2
|
| gptkbp:hasCapacity |
educational resources
medical professionals support groups |
| gptkbp:hasService |
history of recurrent angioedema
low C1 inhibitor levels low_C4_levels |
| https://www.w3.org/2000/01/rdf-schema#label |
hereditary angioedema
|
| gptkbp:impact |
both genders
antifibrinolytics C1 inhibitor replacement therapy bradykinin receptor antagonists |
| gptkbp:inheritsFrom |
childhood or adolescence
|
| gptkbp:introduced |
by_William_Osler
|
| gptkbp:manager |
avoidance of triggers
|
| gptkbp:nobleFamily |
autosomal dominant
|
| gptkbp:relatedPatent |
asphyxiation
acquired angioedema gastrointestinal obstruction |
| gptkbp:research |
ongoing studies on new therapies
|
| gptkbp:riskManagement |
stress
trauma hormonal changes surgery family history |
| gptkbp:symptoms |
abdominal pain
swelling difficulty breathing skin rash |
| gptkbp:type |
Type I
Type II |